June 2021 | Oncimmune provides a trading update for the 12 months ended 31 May 2021 (“FY21”)
Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…